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LETTERS
Religious  
Opposition to Polio  
Vaccination 
To the Editor: In 1988, the Glob-
al  Polio  Eradication  Initiative  was 
formed, with the aim of reducing in-
fection with poliomyelitis virus. Two 
decades later in 2008, a total of 1,625 
children contracted acute flaccid pa-
ralysis caused by poliovirus infection 
(1). This finding represented a 150% 
increase over the number of cases in 
2007 (1) and resulted in the reemer-
gence of polio as one of the world’s 
deadliest infections. As of 2009, polio 
remains endemic to 4 countries (India, 
Nigeria,  Pakistan,  and Afghanistan); 
in 2008, cases were also detected in 
14 other countries.
Religious opposition by Muslim 
fundamentalists  is  a  major  factor  in 
the failure of immunization programs 
against polio in Nigeria (2), Pakistan 
(3) and Afghanistan (4). This religious 
conflict in the tribal areas of Pakistan 
is one of the biggest hindrances to ef-
fective  polio  vaccination.  Epidemi-
ologists have detected transmission of 
wild  poliovirus  from  polio-endemic 
districts in Afghanistan, most of which 
are located in the southern region of 
this  country  bordering  Pakistan,  to 
tribal areas of Pakistan (4). This trans-
mission has resulted in new cases of 
polio in previously polio-free districts. 
The local Taliban have issued fatwas 
denouncing vaccination as an Ameri-
can ploy to sterilize Muslim popula-
tions.  Another  common  superstition 
spread by extremists is that vaccina-
tion is an attempt to avert the will of 
Allah. The Taliban have assassinated 
vaccination officials, including Abdul 
Ghani Marwat, who was the head of 
the  government’s  vaccination  cam-
paign in Bajaur Agency in the Paki-
stani  tribal  areas,  on  his  way  back 
from  meeting  a  religious  cleric  (5). 
Over  the  past  year,  several  kidnap-
pings and beatings of vaccinators have 
been reported. Vaccination campaigns 
in Nigeria and Afghanistan have also 
been hampered by Islamic extremists, 
especially in the Nigerian province of 
Kano in 2003, which has resulted in 
the infection returning to 8 previously 
polio-free countries in Africa (2).
Before the Global Polio Eradica-
tion Initiative in 1988, a total of 1,000 
persons/day were infected with a virus 
that would cripple them for the rest of 
their lives (6). To eradicate the disease, 
1 major factor will be to gain support 
of those susceptible to fundamental-
ist propaganda. Islam is a progressive 
religion, and religious leaders should 
be asked to support polio eradication 
programs.  The  Imam  of  the  Ka’aba 
and  other  influential  religious  fig-
ures should be asked to highlight the 
plight of children with polio. Vaccina-
tors operating in conflict-ridden areas 
should be provided protection so that 
they are better able to perform their 
duties. Not only will children in these 
areas be safer, but the disease will not 
be exported to areas where wild polio 
transmission has been interrupted by 
vaccination. Further study of the at-
titudes of Muslim populations toward 
vaccination is needed.
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Recurrent Human 
Rhinovirus  
Infections in  
Infants with  
Refractory Wheezing
To the Editor: Respiratory infec-
tions frequently cause illness among 
pediatric patients worldwide. Human 
rhinovirus (HRV) is a cause of acute 
respiratory tract infections (RTIs) (1); 
co-infections with other respiratory vi-
ruses such as respiratory syncytial vi-
rus (RSV) or influenza virus have also 
been reported. HRV strains have been 
subdivided  into  2  genetic  subgroups 
(HRV-A and HRV-B); a third genetic 
subgroup  has  been  recently  discov-
ered  (2–7).  However,  understanding 
of the epidemiology of novel HRV in-
fection among Asian pediatric patients 
with respiratory illness (4,5) and as-
sociation with recurrent wheezing and 
asthma has been limited (8–10).
We retrospectively analyzed 289 
nasopharyngeal aspirates (NPAs) ob-
tained  from  286  pediatric  patients 
admitted to Chulalongkorn Memorial 
Hospital in Bangkok, Thailand, during 
2006–2007. The study was reviewed 
and approved by the Institutional Re-
view Board, Chulalongkorn University,   
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Bangkok,  Thailand.  Each  specimen 
was  tested  for  common  respiratory 
viruses such as RSV, HRV, parainflu-
enza 1–3, influenza A and B viruses, 
adenovirus, human metapneumovirus, 
and  human  bocavirus.  On  the  basis 
of phylogenetic analysis of the VP4 
region, we identified 2 patients who 
had been admitted with 5 episodes of 
acute RTIs and subsequent recurrent 
wheezing associated with HRV-A and 
HRV-C.
The first patient was an infant girl 
whose first episode of breathing diffi-
culty was at 5 months of age; a diag-
nosis of RSV bronchiolitis was made. 
She was hospitalized with respiratory 
failure and required mechanical ven-
tilation for 3 days. At 6 months, she 
had pneumonia and wheezing. At 14 
months,  she  had  a  low-grade  fever, 
mild cough, breathing difficulty, and 
wheezing. While she was hospitalized 
for 7 days, a novel HRV-C (FJ435240) 
was  identified  by  seminested  PCR, 
and  RSV  was  detected  by  reverse 
transcription–PCR.  Seven  months 
later, she had recurrent wheezing and 
respiratory distress. Virologic analysis 
indicated that she was co-infected with 
a divergent HRV-C strain (FJ435256) 
and influenza A virus. Nucleotide se-
quence identity score between the 2 
isolated  strains  of  HRV-C  indicated 
a  different  cluster  (identity  score 
70.1%).
The second patient was an infant 
boy with a diagnosis of acute bronchi-
olitis at 7 months of age. His under-
lying condition was congenital heart 
disease and an allergy to cow’s milk 
protein.  Initial  NPA  showed  HRV-A 
(FJ435274) and RSV by reverse tran-
scription–PCR. Two months later, he 
had viral pneumonia and acute exacer-
bation of his reactive airway disease. 
He received systemic corticosteroids 
and  a  nebulized  bronchodilator.  His 
clinical  course  was  complicated  by 
3 episodes of supraventricular tachy-
cardia  that  were  controlled  with  ad-
enosine  and  cordarone.  NPA  was 
again positive for HRV-A (FJ435284). 
Three weeks later, he had upper re-
spiratory  tract  symptoms,  low-grade 
fever,  and  protracted  cough;  blood 
oxygen saturation was low and respi-
ratory distress had rapidly increased. 
An NPA showed HRV-C (FJ435299). 
He received systemic corticosteroids 
and was discharged with corticoster-
oid inhalation. Comparison between 2 
HRV-A strains isolated showed 82.5% 
nucleotide sequence identity. The se-
quence of the HRV-C strain also dis-
played  51.2%  and  61.1%  nucleotide 
identity  to  FJ435274  and  FJ435284, 
respectively. Results of phylogenetic 
analysis are shown in the Figure.
A novel HRV-C infection in as-
sociation  with  acute  lower  RTI  was 
diagnosed  in  the  first  patient  during 
her  fourth  and  fifth  hospitalizations. 
The 2 strains isolated are within the 
same genetic group and display 70% 
nucleotide similarity, which suggests 
that  this  infant  was  infected  with  2 
different virus strains. The second pa-
tient was infected with HRV-A during 
his first hospitalization. His condition 
subsequently progressed to refractory 
wheezing.  Both  patients  were  co-in-
fected with RSV when a diagnosis of 
infection with lower RTIs was made. 
Two  HRV-A  strains  detected  in  the 
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Figure. Phylogenetic analysis of nucleotide sequences of the virus capsid protein (VP4) 
region  of  5  human  rhinovirus  (HRV)  strains  (shown  in  boldface)  isolated  from  289 
nasopharyngeal aspirate specimens, including those of 2 infants with refractory wheezing 
(C1 and C2), on the basis of amplification of VP4/2 by seminested reverse transcription–
PCR.  The  tree  was  constructed  by  using  the  neighbor-joining  method  and  Kimura’s 
2-parameter distance with bootstrap replicated from 1,000 trees by using MEGA 4.0 (www.
megasoftware.net). Scale bar indicates number of nucleotide substitutions per site. Human 
enterovirus (HEV) was used as an outgroup for comparison.
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second patient were within the same 
subgroup, but similarity in nucleotide 
sequences was only 82.5%. This result 
suggests that this patient was infected 
with 2 different virus strains of HRV-A 
and a strain of HRV-C.
Comparison of the HRV-A strains 
with  the  HRV-C  strain  showed  that 
they belonged to different subgroups 
and had low similarity for nucleotide 
sequences. The second patient had 3 
distinct  rhinovirus  infections  over  3 
months, and each was associated with 
illness requiring hospitalization. Both 
patients had underlying diseases, reac-
tive airway diseases, and repeated epi-
sodes of RTI that may have rendered 
them vulnerable to reinfection, com-
promising their immune responses.
Complete  coding  sequences  of 
HRV-A and HRV-C have been deter-
mined (4,7). However, little is known 
about their involvement in the patho-
genesis  of  recurrent  wheezing  in 
young  children. According  to  recent 
reports, HRV-C has been detected in 
hospitalized children with lower RTI 
in the People’s Republic of China (5). 
Possible association of novel infection 
with HRV and exacerbation of asthma 
in children has also been reported (6). 
We  report  HRV-A  and  HRV-C  co-
infections  in  conjunction  with  other 
respiratory viruses, such as RSV, as a 
potential cause of recurrent wheezing 
in infants with acute lower RTIs. Co-
infections  with  HRV-A  and  HRV-C 
may contribute to increased virulence 
and subsequent pathogenesis of other 
respiratory viruses. Additional studies 
will be required to further explore the 
clinical role of novel HRVs.
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Extensively  
Drug-Resistant  
Acinetobacter  
baumannii 
To  the  Editor:  In  the  1990s, 
patients  infected  with  vancomycin-
resistant  Enterococcus  faecium  were 
successfully treated with new antimi-
crobial drugs. However, it is unlikely 
that new antimicrobial drugs will be 
available  in  the  near  future  to  treat 
patients  infected  with  gram-negative 
pathogens  such  as  Acinetobacter 
baumannii (1). No new antimicrobial 
drugs active against this organism are 
currently in clinical trials (www.clini-
caltrials.gov). We report a patient in-
fected with A. baumannii that lacked 
susceptibility  to  all  commercially 
available antimicrobial drugs.
The patient, a 55-year-old woman, 
had a prolonged stay in an intensive 
care  unit  at  the  University  of  Pitts-
burgh  Medical  Center  (Pittsburgh, 
PA, USA) after undergoing lung trans-
plantation. In the tenth postoperative 
week,  ventilator-associated  pneumo-
nia developed, which was caused by 
A. baumanni that lacked susceptibil-
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